Allena Pharmaceuticals

Allena Pharmaceuticals is focused on treating complex metabolic conditions that can lead to significant and costly health complications. The Company aims to reduce the burden of toxic metabolites such as oxalate and uric acid. These metabolites are normal byproducts of cellular activity and are also derived from the typical diet. In certain circumstances, they can build up and lead to complications such as hyperoxaluria and kidney stones (nephrolithiasis) in the case of oxalate, or hyperuricemia and gout in the case of uric acid.
Company Growth (employees)
Type
Private
HQ
Newton, US
Founded
2010
Size (employees)
33 (est)+4%
Allena Pharmaceuticals was founded in 2010 and is headquartered in Newton, US

Key People/Management at Allena Pharmaceuticals

Alexey Margolin

Alexey Margolin

CEO
Hugh Wight

Hugh Wight

Vice President of Technical Operations

Allena Pharmaceuticals Office Locations

Allena Pharmaceuticals has an office in Newton
Newton, US (HQ)
One Newton Executive Park, Suite 202

Allena Pharmaceuticals Financials and Metrics

Summary Metrics

Allena Pharmaceuticals's latest funding round in December 2015 was reported to be $53 m. In total, Allena Pharmaceuticals has raised $93 m

Allena Pharmaceuticals's Web-traffic and Trends

Allena Pharmaceuticals Company Life and Culture

You may also be interested in